Valuation: Teleflex Incorporated

Market Cap 5.91B 5.19B 4.79B 4.42B 8.38B 566B 8.55B 57.55B 22.36B 277B 22.2B 21.71B 962B P/E 2026 *
46x
P/E 2027 * 18.7x
Enterprise Value 5.91B 5.19B 4.79B 4.42B 8.38B 566B 8.55B 57.55B 22.36B 277B 22.2B 21.71B 962B EV / Sales 2026 *
2.58x
EV / Sales 2027 * 2.46x
Free-Float
91.41%
Yield 2026 *
1.02%
Yield 2027 * 1.03%
1 day-1.52%
1 week+1.18%
Current month+3.57%
1 month-0.35%
3 months+10.29%
6 months+19.33%
Current year+7.57%
1 week 128.26
Extreme 128.26
136.69
1 month 120.86
Extreme 120.86
136.69
Current year 100.18
Extreme 100.18
139.67
1 year 100.18
Extreme 100.18
139.67
3 years 100.18
Extreme 100.18
262.97
5 years 100.18
Extreme 100.18
428.36
10 years 100.18
Extreme 100.18
449.38
Manager TitleAgeSince
Chief Executive Officer - 2026-06-07
Director of Finance/CFO - 2025-04-01
Compliance Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 66 2008-12-31
Director/Board Member 72 2015-04-30
Director/Board Member 70 2016-09-12
Date Insider Type Main position Quantity % Market Cap.
06-07Free

Director

7,850 0.0177%
06-07Free

Chief Executive Officer

80,054 0.1808%
05-14Free

Director

3,487 0.0079%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%+1.18%+9.69%-45.10% 5.91B
-0.49%+3.70%-28.32%-10.68% 167B
-2.00%+3.95%-7.06%-4.77% 107B
+1.26%+7.05%+3.60%+60.11% 59.24B
-6.77%-7.86%+44.51%+46.55% 52.99B
-2.95%-0.63%-12.99%-41.01% 43.07B
-4.94%-1.95% - - 36.37B
-0.58%+6.35%-12.57%-43.94% 28.39B
-1.20%-3.71%+59.41%-6.85% 25.16B
-2.04%+1.90%-7.08%+5.37% 21.17B
Average -2.12%+4.94%+5.47%-4.48% 54.65B
Weighted average by Cap. -1.80%+5.25%-4.76%+0.77%

Financials

2026 *2027 *
Net sales 2.29B 2.01B 1.85B 1.71B 3.24B 219B 3.31B 22.27B 8.65B 107B 8.59B 8.4B 372B 2.4B 2.11B 1.94B 1.8B 3.4B 230B 3.47B 23.36B 9.08B 112B 9.01B 8.82B 390B
Net income -4M -3.51M -3.24M -2.99M -5.67M -383M -5.79M -38.94M -15.13M -187M -15.02M -14.69M -651M 141M 124M 114M 106M 200M 13.5B 204M 1.37B 533M 6.61B 529M 518M 22.94B
Net Debt - -
Logo Teleflex Incorporated
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Employees
15,500
Date Price Change Volume
26-07-08 US$131.46 -1.56% 76,107
26-07-07 US$133.54 -0.58% 478,945
26-07-06 US$134.32 +0.25% 435,022
26-07-02 US$133.99 +3.27% 673,199
26-07-01 US$129.75 +2.36% 427,229
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
133.54USD
Average target price
145.89USD
Spread / Average Target
+9.25%

Quarterly revenue - Rate of surprise